World Heart Day – more guidance for medicines developers

  • Email
  • Help

News

27/09/2013

World Heart Day – more guidance for medicines developers

The European Medicines Agency supports World Heart Day, which is taking place on Sunday 29 September 2013.

The Agency plays an important role in the authorisation of medicines to treat heart disease, recommending the authorisation of a number of medicines in the European Union (EU) for cardiovascular diseases.

The Agency also publishes guidelines describing how studies of medicines for the treatment of cardiovascular disease should be designed and carried out. Such guidelines are intended to help pharmaceutical industry and public institutions carry out clinical research in this domain.

The Agency’s Cardiovascular Working Party (CVSWP), which is composed of European experts selected from or associated with the EU national agencies with specific expertise in cardiovascular disease, is in the process of developing or revising a number of guidance documents in this area:

About World Heart Day

World Heart Day is held each year on 29 September and is dedicated to informing people around the globe that heart disease and stroke are the world’s leading cause of death. This year’s theme will focus on a life-course approach to the prevention and control of cardiovascular disease with a focus on women and children.

Related information